We show that fibroblasts treated with supernatants from pro-inflammatory macrophages, similar to T2D wounds, increase Setdb2 and repress myofibroblast genes and that treatment with a commercially available TNF-α decoy receptor can reduce upregulation of Setdb2. The gene discussed is SETDB2; the disease is type 2 diabetes mellitus.